NewDog Symptoms&Cat SymptomsNew

Search Insurance
Find a dog or cat
Australian Shepherd - vet costs and insurance
Moderate risk

Australian Shepherd health problems & vet costs

  1. Health Problems
  2. Insurance Traps
  3. Common Questions
By Marcel Janik · Last updated Sep 5, 2026

Average Australian Shepherd lifespan is 12-15 years - but 1 in 2 carry the MDR1 gene that makes common medications potentially fatal. Add hip dysplasia, epilepsy, eye diseases, and merle-related deafness to the list, and this smart, energetic breed needs smarter-than-average health planning. Here's what you need to know.

Lifetime vet costs

across 389 dog breeds

Australian Shepherd: $16,000 Pricier than 61% of breeds Average lifespan: 12-15 years

How I calculate numbers →

Measured risks

How often they happen is backed by published studies.

MDR1 Drug Sensitivity 50%
$0.1-0.1k Treatment
What is this?Hide
Breed study Approximately 50% of tested Australian Shepherds and Mini American Shepherds carry the mutant MDR1 (ABCB1) allele, second only to Collies in mutation frequency (Washington State University Program in Individualized Medicine / Mealey lab) - a genotype frequency from a self-selected tested population, likely the reference standard for this mutation

A gene mutation that lets certain common drugs (like ivermectin and some anesthetics) cross into the brain and cause severe, sometimes fatal reactions. This is one of the best-documented and most important genetic risks of any breed on this site - roughly half the breed carries it.

Allergies & Skin Problems 12.6%
$1-4k/year
What is this?Hide
All dogs 12.58% one-year period prevalence of any skin disorder, all UK dogs (O'Neill et al. 2021, BMC Veterinary Research)

Chronic skin inflammation causing persistent itching. No Australian Shepherd-specific figure was confirmed - this is the all-dogs baseline. Full profile →

Epilepsy & Seizures 0.6%
$0.5-3k/year
What is this?Hide
All dogs [6] 0.62% (0.57-0.67) prevalence of epilepsy of unknown origin, all UK dogs (Kearsley-Fleet et al. 2013, Veterinary Record) - Australian Shepherd wasn't confirmed as significantly predisposed in this study

A seizure disorder. No confirmed Australian Shepherd-specific figure was found - this is the all-dogs baseline. Full profile →

Known risks

Well documented in the breed - but no study has counted how often.

Collie Eye Anomaly (CEA) ~17% carriers
$1.5-4k Surgery
What is this?Hide
Breed study NHEJ1 deletion variant carrier frequency approximately 17% in Australian Shepherds (Italian and Thai genotyping surveys) - a carrier frequency, not a clinical disease rate; actual affected (choroidal hypoplasia present) dogs are a smaller subset since this is recessive

A congenital eye malformation affecting the choroid layer, ranging from unnoticeable to vision-threatening. What's measured here is the gene-variant frequency - not every carrier or even every affected dog loses vision. Full profile →

Hip Dysplasia ~6.3%
$1.5-7k/hip Treatment
What is this?Hide
Not measured Breed-oriented sources cite 15-20%, but this couldn't be traced to a primary OFA table in this audit; OFA screening database: 6.3% of 50,266 submitted hip x-rays graded abnormal. Voluntary submissions - true population rate may differ.

A malformed hip joint. Breed-club estimates circulate widely, but we couldn't confirm a figure from a primary, citable source (live OFA data would need to be pulled directly). Full profile →

Elbow Dysplasia ~4.8%
$1.5-4k Surgery
What is this?Hide
Not measured No confirmed Australian Shepherd-specific prevalence found; breed-oriented sources cite 5-15% but this couldn't be traced to a primary source; OFA screening database: 4.8% of 21,695 submitted elbow x-rays graded abnormal. Voluntary submissions - true population rate may differ.

Abnormal elbow joint development causing chronic front-leg lameness. No confirmed Australian Shepherd-specific figure was found. Full profile →

Hypothyroidism ~2.9%
$0.2-1k/year
What is this?Hide
Not measured [5] Australian Shepherd is absent from both the predisposed and protected breed lists in the largest UK VetCompass hypothyroidism study (O'Neill et al. 2022, Canine Medicine and Genetics); all-dogs baseline is 0.23%/year; OFA thyroid screening: 2.9% of 526 panels abnormal (mostly compensated autoimmune thyroiditis - antibodies that often progress to hypothyroidism; 0.0% overt disease). Voluntary submissions - true population rate may differ.

An underactive thyroid causing weight gain and lethargy. Australian Shepherd does not appear among predisposed breeds in the largest available study. Full profile →

Hereditary Deafness Documented, not counted
$0.1-0.4k Treatment
What is this?Hide
Breed study [3] Australian Shepherd was one of the breeds studied in the definitive merle-deafness paper (32 dogs in a 243-dog multi-breed cohort: 11% unilateral, 5% bilateral deafness on BAER testing overall) - a breed-specific breakdown wasn't available in this audit (Strain 2009, Journal of Veterinary Internal Medicine)

Merle coat color is genetically linked to deafness risk, especially in double-merle dogs. Australian Shepherd was included in the key study on this, but a breed-specific rate couldn't be confirmed separately from the pooled multi-breed data.

Cancer (Hemangiosarcoma & Lymphoma) Documented, not counted
$3-12k+ Treatment
What is this?Hide
Breed study [4] Australian Shepherd Health & Genetics Institute 2009-10 owner-reported breed survey: 5% hemangiosarcoma, 2% lymphoma, ~60% of deaths attributed to cancer overall - an owner-reported breed-club survey, not peer-reviewed veterinary epidemiology; self-selection and response bias apply

Blood-vessel and lymph-node cancers. A breed health survey found these among the leading causes of death - real data, but from an owner-reported survey rather than clinical records, which tends to be a less rigorous evidence tier. Full profile →

How we know these numbers
  • Confirmed = measured or gene-confirmed specifically in this breed
  • Breed study = scientists counted it in this exact breed
  • Body type = comes from the dog's build - size, skull, skin
  • Genetic risk = the gene is proven, the odds are not
  • All dogs = an average for all dogs, not this breed
  • Not measured = nobody has counted it yet
  • How we grade evidence →
Red flags
Insurance Traps

Most owners sign a policy based on ads, but learn the real rules only when their first big claim gets denied.

MDR1 = Genetic Exclusion Risk Exclusion
If your Aussie tests positive for the MDR1 mutation, some insurers classify any adverse drug reaction as a 'known genetic condition' and deny the claim. An emergency vet visit for accidental ivermectin exposure can hit $1,000-$5,000 - and the insurer says you 'knew the risk.'
Eye Conditions: Hereditary Blanket Denial Exclusion
CEA, cataracts, and PRA are all hereditary. One eye diagnosis on your Aussie's record and insurers use the 'hereditary condition' exclusion to deny coverage for all eye problems - even unrelated ones. Cataract surgery alone costs $1,500-$4,000 per eye.
Epilepsy: Lifelong Med Cap Pre-existing
Epilepsy medication runs $500-$3,000/year for life. Many policies cap 'chronic condition' payouts or raise your premium 25-40% after the first seizure claim. By year 3, you're paying more in premiums than the medication costs - but you can't drop coverage because epilepsy is now pre-existing everywhere else.
Double Merle = Congenital Exclusion Waiting period
If your Aussie is a double merle (or even suspected), deafness and vision problems are classified as 'congenital defects' - permanently excluded from day one. No waiting period helps. Even single merles with minor hearing issues can trigger this exclusion for all future ear and eye claims.
Australian Shepherd - vet costs and insurance

Common Questions

Real answers about costs, treatment, and insurance coverage.

What are the most common Australian Shepherd health problems?
Top problems: MDR1 drug sensitivity (50% carriers), hip dysplasia (6.3% of OFA-screened dogs), eye diseases (CEA, cataracts, PRA), epilepsy, allergies, merle-related deafness, cancer, and hypothyroidism. MDR1 is most dangerous - it makes common medications potentially fatal. A $50 DNA test can save your dog's life.
What is the Australian Shepherd lifespan?
The average Australian Shepherd lifespan is 12-15 years. Female Aussies tend to live slightly longer than males. Cancer is the leading cause of death, followed by epilepsy complications. Maintaining a healthy weight, MDR1 DNA testing, and annual eye exams are the three most impactful things for longevity.
What is MDR1 in Australian Shepherds?
MDR1 (Multi-Drug Resistance 1) is a genetic mutation affecting about 50% of Australian Shepherds. It prevents drugs from leaving the brain, causing potentially fatal neurotoxicity. Dangerous drugs include ivermectin (dewormer), loperamide (Imodium), and some anesthetics. A DNA test costs $50-$150 and should be done before medication or surgery. Emergency treatment costs $1,000-$5,000.
What are common Australian Shepherd eye problems?
Australian Shepherds are prone to three major eye conditions: Collie Eye Anomaly (CEA), Hereditary Cataracts (surgery $1,500-$4,000 per eye), and Progressive Retinal Atrophy (PRA). All three are genetic. CERF eye exams ($30-$60) should be done annually. Blue merle Aussies have additional eye risks.
Do Australian Shepherds have seizures?
Yes. Idiopathic epilepsy is one of the most common neurological conditions in Australian Shepherds. Seizures typically begin between ages 1-5. A single seizure workup costs $500-$2,000 (bloodwork, MRI, neurologist). Lifelong anti-seizure medication runs $500-$3,000/year depending on the drug. Most Aussies with epilepsy live normal lifespans with proper medication, but the condition requires lifelong management.
Do blue merle Australian Shepherds have more health problems?
Blue merle Aussies have the same general health risks as other colors, but merle-to-merle breeding creates 'double merles' with significantly higher rates of deafness (up to 10x) and eye defects including blindness. Even single merles can have hearing issues. A BAER hearing test ($100-$400) is recommended. The merle gene itself isn't a health problem - irresponsible breeding of merle-to-merle is.
How much does Australian Shepherd hip dysplasia treatment cost?
Hip dysplasia treatment costs $1,500-$7,000 per hip via total hip replacement (THR) or $1,500-$3,000 via femoral head ostectomy (FHO). Non-surgical management costs $500-$2,000/year. About 6.3% of OFA-screened Aussies are graded dysplastic. OFA hip screening should be done by age 2, especially before breeding.
What are common Australian Shepherd skin problems?
Australian Shepherds suffer from environmental allergies, food sensitivities, and contact dermatitis. Symptoms include chronic itching, hot spots, and scabs. Food elimination diets cost $200-$500. Allergy testing runs $200-$600. Ongoing treatment with Apoquel or Cytopoint costs $1,000-$4,000/year. Some Aussies need lifelong allergy management.
How much does pet insurance cost for an Australian Shepherd?
Pet insurance for Australian Shepherds starts at $30-$55/month for a puppy, increasing 15-20% annually. By age 8-10, premiums can reach $100-$180/month. Over a lifetime, that's $14,000-$20,000+ in premiums. Before signing, verify that MDR1 reactions, hereditary eye conditions, and epilepsy are explicitly covered - these are the three most expensive Aussie-specific exclusion risks.
Is pet insurance worth it for an Australian Shepherd?
Australian Shepherds face expensive genetic conditions: hip surgery $1,500-$7,000, cataract surgery $1,500-$4,000 per eye, epilepsy medication $500-$3,000/year for life, and MDR1 emergencies $1,000-$5,000. Enroll as a puppy before symptoms appear to protect against catastrophic costs. Verify that hereditary eye conditions, epilepsy, and MDR1 drug reactions are covered.
What is the average yearly vet cost for an Australian Shepherd?
A healthy Australian Shepherd costs $700-$1,500/year in routine care plus $50-$150 for annual eye exams. With chronic conditions, costs jump to $2,500-$6,000/year. Senior Aussies with multiple issues can exceed $8,000-$12,000/year. The MDR1 DNA test is a one-time $50-$150 cost that can prevent a $5,000 emergency.
What questions should I ask before insuring my Australian Shepherd?
Ask in writing: (1) Are MDR1 drug reactions covered? (2) Are hereditary eye conditions (CEA, cataracts, PRA) covered? (3) What's the waiting period for orthopedic conditions? (4) How do you handle epilepsy - is there a payout cap? (5) Are congenital conditions like merle-related deafness covered? (6) Show premium examples at ages 1, 5, 8, and 10.

Similar dogs

Border Collie Medium risk Border Collie Shetland Sheepdog Medium risk Shetland Sheepdog Australian Cattle Dog Medium risk Australian Cattle Dog Airedale Terrier Not enough data Airedale Terrier American Foxhound Not enough data American Foxhound Anglo French Hound De Petite Venerie Not enough data Anglo French Hound De Petite Venerie Ariegeois Not enough data Ariegeois Ariegeois Short Haired Pointer Not enough data Ariegeois Short Haired Pointer Artois Hound Not enough data Artois Hound Austrian Short Haired Hound Not enough data Austrian Short Haired Hound Auvergne Short Haired Pointer Not enough data Auvergne Short Haired Pointer Barbet Not enough data Barbet
Marcel Janik, founder of RealVetCost
Marcel Janik Founder of realvetcost.com

My mother-in-law's boxer. Problem. $1,200 in tests, no answers. Another vet solved it with $8 pills. When you're scared, you'll pay anything - and some vets price accordingly. So I built what I couldn't find: real costs, real exclusions, plain language. Not selling policies.

@uxcodecz

Sources

Research and data used to compile this profile.

  1. 1 Washington State University Program in Individualized Medicine (PrIMe) / Mealey KL lab - MDR1 (ABCB1) mutation frequency by breed.
  2. 2 NHEJ1 deletion (Collie Eye Anomaly) carrier frequency genotyping surveys, Italian and Thai populations.
  3. 3 Strain GM (2009) - Prevalence of Deafness in Dogs Heterozygous or Homozygous for the Merle Allele. Journal of Veterinary Internal Medicine 23(2):282.
  4. 4 Australian Shepherd Health & Genetics Institute (ASHGI) - 2009-10 owner-reported breed health survey.
  5. 5 O'Neill DG, et al. (2022) - Frequency, breed predispositions and other demographic risk factors for diagnosis of hypothyroidism in dogs. Canine Medicine and Genetics 9:11.
  6. 6 Kearsley-Fleet L, et al. (2013) - Prevalence and risk factors for canine epilepsy of unknown origin in the UK. Veterinary Record 172(13):338.